Growth Metrics

Adaptive Biotechnologies (ADPT) Short-term Investments (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Short-term Investments for 8 consecutive years, with $156.5 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 10.26% to $156.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $156.5 million through Dec 2025, down 10.26% year-over-year, with the annual reading at $156.5 million for FY2025, 10.26% down from the prior year.
  • Short-term Investments hit $156.5 million in Q4 2025 for Adaptive Biotechnologies, down from $157.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $540.6 million in Q1 2021 to a low of $142.8 million in Q1 2025.
  • Historically, Short-term Investments has averaged $269.8 million across 5 years, with a median of $265.0 million in 2022.
  • Biggest YoY gain for Short-term Investments was 102.12% in 2021; the steepest drop was 62.11% in 2021.
  • Year by year, Short-term Investments stood at $214.0 million in 2021, then soared by 90.74% to $408.2 million in 2022, then crashed by 31.07% to $281.3 million in 2023, then tumbled by 38.02% to $174.4 million in 2024, then decreased by 10.26% to $156.5 million in 2025.
  • Business Quant data shows Short-term Investments for ADPT at $156.5 million in Q4 2025, $157.7 million in Q3 2025, and $154.7 million in Q2 2025.